Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tan A Ince

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Nature|December 25, 2007
Reprogramming of human somatic cells to pluripotency with defined factorsIn-Hyun Park, Rui Zhao, Jason A West, et al.
Cell|August 7, 2012
HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancersMarc L Mendillo, Sandro Santagata, Martina Koeva, et al.
Cancer Cell|August 17, 2013
A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cellsFabio Petrocca, Gabriel Altschuler, Shen Mynn Tan, et al.
Cancer Discovery|February 4, 2012
Ovarian cancer spheroids use myosin-generated force to clear the mesotheliumMarcin P Iwanicki, Rachel A Davidowitz, Mei Rosa Ng, et al.
Advances in Anatomic Pathology|February 28, 2003
Biomarkers in diagnostic obstetric and gynecologic pathology: a reviewMarisa R Nucci, Diego H Castrillon, Hongwei Bai, et al.
The American Journal of Pathology|October 9, 2002
Loss of p63 expression is associated with tumor progression in bladder cancerMarshall J Urist, Charles J Di Como, Ming-Lan Lu, et al.
Science Translational Medicine|June 20, 2020
Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapyAdriana De La Fuente, Serena Zilio, Jimmy Caroli, et al.
Genes & Development|August 6, 2013
Chaperone-mediated autophagy degrades mutant p53Helin Vakifahmetoglu-Norberg, Minsu Kim, Hong-Guang Xia, et al.
Genes & Development|April 3, 2016
Corrigendum: Chaperone-mediated autophagy degrades mutant p53Helin Vakifahmetoglu-Norberg, Minsu Kim, Hong-Guang Xia, et al.
Breast Cancer Research and Treatment|March 20, 2016
Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapySeth A Wander, Dekuang Zhao, Alexandra H Besser, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Nature|December 25, 2007
Reprogramming of human somatic cells to pluripotency with defined factorsIn-Hyun Park, Rui Zhao, Jason A West, et al.
Cell|August 7, 2012
HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancersMarc L Mendillo, Sandro Santagata, Martina Koeva, et al.
Cancer Cell|August 17, 2013
A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cellsFabio Petrocca, Gabriel Altschuler, Shen Mynn Tan, et al.
Cancer Discovery|February 4, 2012
Ovarian cancer spheroids use myosin-generated force to clear the mesotheliumMarcin P Iwanicki, Rachel A Davidowitz, Mei Rosa Ng, et al.
Advances in Anatomic Pathology|February 28, 2003
Biomarkers in diagnostic obstetric and gynecologic pathology: a reviewMarisa R Nucci, Diego H Castrillon, Hongwei Bai, et al.
The American Journal of Pathology|October 9, 2002
Loss of p63 expression is associated with tumor progression in bladder cancerMarshall J Urist, Charles J Di Como, Ming-Lan Lu, et al.
Science Translational Medicine|June 20, 2020
Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapyAdriana De La Fuente, Serena Zilio, Jimmy Caroli, et al.
Genes & Development|August 6, 2013
Chaperone-mediated autophagy degrades mutant p53Helin Vakifahmetoglu-Norberg, Minsu Kim, Hong-Guang Xia, et al.
Genes & Development|April 3, 2016
Corrigendum: Chaperone-mediated autophagy degrades mutant p53Helin Vakifahmetoglu-Norberg, Minsu Kim, Hong-Guang Xia, et al.
Breast Cancer Research and Treatment|March 20, 2016
Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapySeth A Wander, Dekuang Zhao, Alexandra H Besser, et al.
Pageof 7